News
BRIEF-Innate Pharma Appoints Jean-Yves Blay To Its Supervisory Board...
www.reuters.com
BRIEF-Innate Pharma Appoints Jean-Yves Blay To Its Supervisory Board. 1 Min Read. Jan 31 (Reuters) - INNATE PHARMA SA: * INNATE ...
INNATE PHARMA : Prof. Jean-Yves Blay appointed to the
www.globenewswire.com
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px;...
Médecine personnalisée et médecine de précision, le combat de demain...
www.presstvnews.com
Médecine personnalisée et médecine de précision, le combat de demain contre les cancers - La Fondation ARC rappelle son engagement dans la médecine...
Press Release: Specific clinical trial methodology needed for rare...
www.rarecancerseurope.org
ESMO Press Conference: Paulo Casali, Vassilis Gonfinopoulos, Jean-Yves Blay and Markus Wartenberg discuss Rare Cancers Europe recommendations for clinical studies in rare cancers. The standard for developing a new treatment is the use of large Phase III controlled clinical trials, which need ...
sortiert nach Relevanz / Datum